These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 78152

  • 21. Angiotensin blockade: its clinical significance.
    Streeten DH, Anderson GH, Dalakos TH.
    Am J Med; 1976 May 31; 60(6):817-24. PubMed ID: 1020761
    [Abstract] [Full Text] [Related]

  • 22. [Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)].
    Beyer J, Liebau G, Steiner B, Hayduk K.
    Klin Wochenschr; 1978 Sep 01; 56(17):859-64. PubMed ID: 713415
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of saralasin in hypertensive patients on chronic hemodialysis.
    Lifschitz MD, Kirschenbaum MA, Rosenblatt SG, Gibney R.
    Ann Intern Med; 1978 Jan 01; 88(1):23-7. PubMed ID: 619754
    [Abstract] [Full Text] [Related]

  • 28. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].
    Glorioso N, Madeddu P, Dessì-Fulgheri P, Meloni F, Palermo M, Fiori C, Rappelli A.
    Boll Soc Ital Cardiol; 1980 Jan 01; 25(9):1035-46. PubMed ID: 7025868
    [No Abstract] [Full Text] [Related]

  • 29. [The saralasin test in the diagnosis of hypertension (author's transl)].
    Bönner G, Helber A, Meurer KA, Hummerich W, Wambach G, Kaufmann W.
    Dtsch Med Wochenschr; 1979 Mar 23; 104(12):432-7. PubMed ID: 436589
    [Abstract] [Full Text] [Related]

  • 30. Clinical experience with saralasin infusion in hypertensive patients.
    Tegtmeyer CJ, Latour EA, Vaughan ED, Ayers CR, Carey RM, Wellons HA.
    Invest Radiol; 1977 Mar 23; 12(6):496-504. PubMed ID: 591250
    [Abstract] [Full Text] [Related]

  • 31. Sympathetic nerve hyperactivity in high-renin hypertension effects of saralasin infusion.
    DeQuattro V, Barbour BH, Campese V, Finck EJ, Miano L, Esler M.
    Mayo Clin Proc; 1977 Jun 23; 52(6):369-73. PubMed ID: 865132
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Detection of renovascular hypertension with angiotensin II blockade.
    Baer L, Parra-Carrilo JZ, Radichevich I, Williams GS.
    Ann Intern Med; 1977 Mar 23; 86(3):257-60. PubMed ID: 842983
    [Abstract] [Full Text] [Related]

  • 36. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
    Anderson GH, Streeten DH, Dalakos TG.
    Circ Res; 1977 Mar 23; 40(3):243-50. PubMed ID: 837471
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of the angiotensin antagonist saralasin on hemodynamics in hypertensive non-uraemic chronic renal disease.
    Brod J, Bahlmann J, Cachovan M, Hubrich W, Pretschner D.
    Nephron; 1980 Mar 23; 25(4):167-72. PubMed ID: 6990284
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.